These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23127)

  • 21. Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain.
    Quik M; Iversen LL
    Eur J Pharmacol; 1979 Jul; 56(4):323-30. PubMed ID: 477728
    [No Abstract]   [Full Text] [Related]  

  • 22. Solubilized serotonin receptors from rat and dog brain. Selective labelling with [3H]ketanserin.
    Ilien B; Schotte A; Laduron PM
    FEBS Lett; 1982 Feb; 138(2):311-5. PubMed ID: 6121721
    [No Abstract]   [Full Text] [Related]  

  • 23. Two binding sites for 3H-spiroperidol on rat striatal membranes.
    Briley M; Langer SZ
    Eur J Pharmacol; 1978 Aug; 50(3):283-4. PubMed ID: 28956
    [No Abstract]   [Full Text] [Related]  

  • 24. Ovine prolactin administration modifies [3H]spiperone binding to striatal membranes of rabbits.
    Eva C; Blengio M; Ferretti C; Muccioli G; Portaleone P
    Brain Res; 1982 Nov; 251(2):388-90. PubMed ID: 7139336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
    Enna SJ; Bennett JP; Burt DR; Creese I; Snyder SH
    Nature; 1976 Sep; 263(5575):338-41. PubMed ID: 8733
    [No Abstract]   [Full Text] [Related]  

  • 26. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
    Marshall AM; Mishra RK
    Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
    [No Abstract]   [Full Text] [Related]  

  • 28. Solubilisation of high-affinity dopamine receptors.
    Gorissen H; Laduron P
    Nature; 1979 May; 279(5708):72-4. PubMed ID: 450076
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of effect of des-tyrosine1-gamma-endorphin on in vivo [3H]spiperone binding.
    Lahti RA; Gay DD
    Eur J Pharmacol; 1982 May; 80(1):127-9. PubMed ID: 6124435
    [No Abstract]   [Full Text] [Related]  

  • 30. Specific in vivo binding of neuroleptic drugs in rat brain.
    Laduron P; Leysen J
    Biochem Pharmacol; 1977 May; 26(10):1003-7. PubMed ID: 861040
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and biological evaluation of p-bromospiperone as potential neuroleptic drug.
    Huang CC; Friedman AM; So R; Simonovic M; Meltzer HY
    J Pharm Sci; 1980 Aug; 69(8):984-6. PubMed ID: 6105200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ; Spuhler K; Prasad KN; Seeman P
    Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of 3H-spiroperidol binding by an endogenous material from brain.
    Lahti RA; Gay DD; Barsuhn C
    Eur J Pharmacol; 1978 Dec; 53(1):117-8. PubMed ID: 738355
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroleptic receptors: stereoselectivity for neuroleptic enantiomers.
    Seeman P; Westman K; Protiva M; Jílek J; Jain PC; Saxena AK; Anand N; Humber L; Philipp A
    Eur J Pharmacol; 1979 Jun; 56(3):247-51. PubMed ID: 38971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical properties of spiperone binding to rat brain membranes.
    Sundermann RH; Wooten GF
    Pharmacology; 1980; 21(4):295-305. PubMed ID: 6106952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of ADTN to define specific 3H-spirerone binding to receptors in brain.
    Quik M; Iversen LL; Larder A; Mackay AV
    Nature; 1978 Aug; 274(5670):513-4. PubMed ID: 672981
    [No Abstract]   [Full Text] [Related]  

  • 37. [3H]spiroperidol binding on lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment.
    Le Fur G; Zarifian E; Phan T; Cuche H; Flamier A; Bouchami F; Burgevin MC; Loo H; Gérard A; Uzan A
    Life Sci; 1983 Jan; 32(3):249-55. PubMed ID: 6130459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H; Sudo K; Sano M
    Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3H-Apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment.
    Leysen JE
    Adv Biochem Psychopharmacol; 1980; 24():123-32. PubMed ID: 6105770
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of varying 3H-spiperone concentration on its binding parameters.
    Hartley EJ; Seeman P
    Life Sci; 1978 Aug; 23(5):513-7. PubMed ID: 692274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.